All In Biotech

Free tool

FAERS Monitor: Tolsura

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208901 or its brand name (Tolsura, Itraconazole). Reports on generic versions are filed under their own applications.

Reports

9,411

Serious

8,437

90% of reports

Hospitalization

3,574

Death reported

1,977

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,040
  • drug interaction1,022
  • off label use518
  • pyrexia494
  • pneumonia412
  • febrile neutropenia341
  • nausea334
  • dyspnoea333
  • condition aggravated320
  • diarrhoea304
  • neutropenia276
  • anaemia251
  • sepsis247
  • fatigue243
  • rash236

Reports by year received

View as table
YearReports
2004146
200596
2006146
2007189
2008208
2009288
2010250
2011555
2012464
2013312
2014286
2015446
2016341
2017431
2018589
2019661
2020712
2021659
2022538
2023569
2024524
2025527
2026473

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,748 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug interactionSignal1,02214.513.712,830
febrile neutropeniaSignal34111.510.43,267
sepsisSignal2475.04.4779
neutropeniaSignal2764.54.0763
pyrexiaSignal4943.22.9754
anaemiaSignal2512.92.6323
pneumoniaSignal4122.82.6499
condition aggravatedSignal3202.42.1251
drug ineffective1,0401.81.7366
off label use5181.31.242
dyspnoea3331.31.225
rash2361.21.19
diarrhoea3041.10.91
nausea3340.90.81
fatigue2430.70.633

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.